US Broker Ratings

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Promising Biotech with a 115% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a biopharmaceutical company at the forefront of developing transformative therapies, presents an enticing proposition for investors looking to capitalize on the..

Artivion, Inc. (AORT) Stock Analysis: Healthcare Innovator Poised for 60% Upside

Artivion, Inc. (NASDAQ: AORT), a dynamic player in the healthcare sector specializing in medical devices, is attracting investor interest with its promising outlook and robust product..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 252.82% Potential Upside with Strong Buy Ratings

Investors eyeing the healthcare sector may want to turn their attention to Opko Health, Inc. (NASDAQ: OPK), a company that presents a compelling investment opportunity with..

Azenta, Inc. (AZTA) Investor Outlook: Navigating a Challenging Landscape with Strategic Partnerships

Azenta, Inc. (NASDAQ: AZTA) stands at an intriguing crossroads, poised between growth opportunities and operational challenges. As a player in the healthcare sector’s Medical Instruments &..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Can 44.7% Revenue Growth Justify Its Sky-High Forward P/E?

For investors looking at the potential of Establishment Labs Holdings Inc (NASDAQ: ESTA), the healthcare company specializing in medical devices, particularly breast implants under the Motiva..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Potential with a Strong 20.89% Return on Equity

For investors seeking opportunities in the healthcare sector, Pediatrix Medical Group, Inc. (NASDAQ: MD) presents a compelling, albeit complex, profile. With a market capitalization of $2.15..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: An Insightful Look at Potential 53% Upside

In the rapidly evolving biotechnology sector, Dyne Therapeutics, Inc. (NASDAQ: DYN) is emerging as a noteworthy contender. This clinical-stage company is focused on developing innovative therapeutics..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Navigating Growth with a 4.9% Upside Potential

BioLife Solutions, Inc. (BLFS), a key player in the healthcare sector, specifically in the medical instruments and supplies industry, is making waves with its innovative contributions..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Evaluating a 26.74% Potential Upside Amidst Volatile Revenue Growth

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands as a notable player in the biotechnology sector, primarily focused on rare disorders. With a market capitalization of $6.29 billion,..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 12% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the U.S. healthcare sector, is making waves with its innovative approach to non-opioid pain management solutions. With..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 22% Potential Upside

Investors seeking opportunities in the healthcare sector may find U.S. Physical Therapy, Inc. (NYSE: USPH) an intriguing prospect. This Houston-based company, with a market capitalization of..

Ligand Pharmaceuticals Inc. (LGND) Stock Analysis: Exploring the 8.67% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has captured the attention of investors with its strong presence in the biotechnology sector, bolstered by an impressive 8.67% potential upside..

Edgewise Therapeutics, Inc. (EWTX)

⚠️ No article content returned.

..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a Potential 138% Upside in the Biotech Sector

Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is captivating investor interest with its innovative approach to cancer treatment through cutting-edge immunotherapies...

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a 165% Potential Upside in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX) has caught the eye of investors with its promising potential upside of 165.50%, as indicated by analysts’ average target price. As..

AtriCure, Inc. (ATRC) Stock Analysis: 25.77% Potential Upside in the Medical Instruments Sector

AtriCure, Inc. (NASDAQ: ATRC), a notable player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors with its significant..

GRAIL, Inc. (GRAL) Investor Outlook: Exploring the 28.10% Revenue Growth Potential

GRAIL, Inc. (NASDAQ: GRAL) is carving its niche in the burgeoning healthcare sector, specifically within the diagnostics and research industry. Known for its innovative multi-cancer early..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 66.67% Potential Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA) is capturing the attention of investors with its strategic positioning in the biotechnology sector, and a particularly enticing potential upside of 66.67%...

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Evaluating Stability in the Biotech Sector

Catalyst Pharmaceuticals, Inc. (CPRX), a key player in the biotechnology sector, is making waves with its focus on developing medicines for rare diseases in the United..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a 32.87% Potential Upside with a Focus on Innovative Biotech Solutions

Belite Bio, Inc (BLTE) is creating waves in the biotechnology sector, capturing investor attention with a compelling potential upside of 32.87%. This clinical-stage biopharmaceutical company, based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds